Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Diabetes Discourse

Shaping Diabetes Management With Digital Technology and Genomics

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    The challenges of treating diabetes include long-term monitoring and management, lifestyle change and adherence to medication. How are digital technology and genomics shaping the management of diabetes? Join guest host Dr. Timothy Bailey and his guest Dr. Eric Topol, director of the Scripps Translational Science Institute, as they discuss how digital technologies can improve glucose monitoring and genomics is leading to individualized treatment. Dr. Topol, who does not have diabetes, describes his personal experience living with continuous glucose monitoring for one week.

    Disclosures

    Dr. Eric Topol has disclosed that he has received grants for clinical research from sanofi-avenitis. Dr. Topol has also disclosed that he has served as an advisor or consultant to sanofi-aventis and Daiichi Sankyo.

Recommended
Details
Presenters
Comments
  • Overview

    The challenges of treating diabetes include long-term monitoring and management, lifestyle change and adherence to medication. How are digital technology and genomics shaping the management of diabetes? Join guest host Dr. Timothy Bailey and his guest Dr. Eric Topol, director of the Scripps Translational Science Institute, as they discuss how digital technologies can improve glucose monitoring and genomics is leading to individualized treatment. Dr. Topol, who does not have diabetes, describes his personal experience living with continuous glucose monitoring for one week.

    Disclosures

    Dr. Eric Topol has disclosed that he has received grants for clinical research from sanofi-avenitis. Dr. Topol has also disclosed that he has served as an advisor or consultant to sanofi-aventis and Daiichi Sankyo.

Schedule23 Nov 2024